Daily Briefing: Vie for victory, sensitive bacteria, and models

As good or better: Abbvie’s potential psoriasis drug, risankizumab, has posted positive phase 3 results. It outperformed Humira and J&J’s Stelara. With what they paid for it, you’d hope so. http://bit.ly/2iDcRLs

Touchy-feely: Bacteria never cease to amaze. Promiscuous plasmids. Biofilms. Now a study from the University of Basel indicates that the prokaryotes possess a sense of touch. http://bit.ly/2yY2Rm2

Influenza seasonality model: Researchers used stochastic modeling and seasonal flu surveillance data to establish that flu pandemics can be predictable according to seasonality. http://bit.ly/2yOWYrX

Perfect weather for malaria: A recent study reinforces the theory that malaria transmission and mosquito biting are temperature dependent. However, optimal temperature range remains up for debate. http://bit.ly/2gIhXCc

Selfie studies: Investigating the Self has long been the terrain of philosophy. Now, scientists are attempting to introduce some empirical discipline to the field, by integrating psychology, neuroeconomics, embodied cognition, and social neuroscience. http://bit.ly/2gOfkSR

Leave a Reply

%d bloggers like this: